
Sanofi is exploring a $35B–$43B takeover of Insmed and its blockbuster lung drug Brinsupri as the French pharma giant braces for Dupixent’s looming patent expiration.
PharmExec's 2005 Pharma Knowledge Quiz
almost 21 years ago
PharmExec's 2006 Forecastalmost 21 years ago
Thought Leader: A Q&A with Graham Allawayalmost 21 years ago
Marketing to Professionals: Appealing to Doctor's Emotionsalmost 21 years ago
The PharmExec 2005 Pipeline Reportalmost 21 years ago
From the Editor: Double-Standard Drugsalmost 21 years ago
Global Report: Wanted: Attentionalmost 21 years ago
How Much Do You Really Know About Pharma: Quiz Answersalmost 21 years ago
Washington Report: Big Productionalmost 21 years ago
Leadership: Where Have All the Heroes Gone?almost 21 years ago
Inside DDMAC: A Conversation with Thomas Abrams




